Alerts will be sent to your verified email
Verify EmailVAISHALI
|
Vaishali Pharma
|
Makers Laboratories
|
Mercury Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
7.83 % | 3.8 % | 10.51 % |
|
5yr average Equity Multiplier
|
2.48 | 2.36 | 1.49 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.7 | 1.05 |
|
5yr Avg Net Profit Margin
|
3.68 % | -0.21 % | 6.6 % |
|
Price to Book
|
1.34 | 1.33 | 1.78 |
|
P/E
|
0.0 | 77.74 | 20.91 |
|
5yr Avg Cash Conversion Cycle
|
87.63 Days | 75.08 Days | -4.69 Days |
|
Inventory Days
|
6.87 Days | 107.1 Days | 32.68 Days |
|
Days Receivable
|
177.19 Days | 71.83 Days | 115.65 Days |
|
Days Payable
|
159.49 Days | 106.28 Days | 157.73 Days |
|
5yr Average Interest Coverage Ratio
|
2.55 | 4.73 | 15.15 |
|
5yr Avg ROCE
|
15.65 % | 6.35 % | 13.49 % |
|
5yr Avg Operating Profit Margin
|
5.99 % | 7.59 % | 11.74 % |
|
5 yr average Debt to Equity
|
0.48 | 0.21 | 0.13 |
|
5yr CAGR Net Profit
|
-4.82 % | n/a | -10.08 % |
|
5yr Average Return on Assets
|
3.24 % | 0.25 % | 7.02 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
31.61 % | 61.27 % | 73.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
4.87 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Vaishali Pharma
|
Makers Laboratories
|
Mercury Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|